BOE Tests AI as a Tool for Forecasting Inflation, Greene Says
The Bank of England is experimenting with artificial intelligence to help forecast inflation and hone its communications, according to rate-setter Megan Greene.
She said Thursday that staff were testing a number of use cases for the technology, from providing early warning signals of financial crises to analyzing the labor market.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
Abrego Garcia Returns to US to Face Charges
"Balance of Power: Late Edition" focuses on the intersection of politics and global business. On today's show, Mary Lovely, Senior Fellow at the Peterson Institute for International Economics, shares her thoughts on what to expect Monday as US and Chinese negotiators will resume trade talks in London. Leon Panetta, Former US Secretary of Defense, voices his concerns about the US Supreme Court giving DOGE access to social security data after Elon Musk and President Trump's feud. Zeke Hernandez, Associate Professor at the University of Pennsylvania's Wharton School, discusses Kilmar Abrego Garcia being brought back to the United States to face criminal charges. (Source: Bloomberg)
Yahoo
an hour ago
- Yahoo
HIVE Digital Capacity Crosses 10 EH/s in May, Aims to More Than Double That by Year-End
Bitcoin miner HIVE Digital Technologies (HIVE) has surpassed 10 exahash per second (EH/s) in hashrate capacity, a 58% increase from April, driven by the launch of a 100-megawatt hydro-powered site in Paraguay. The company said in a press release on Friday that it's on track to reach 25 EH/s by the end of 2025. The firm mined 139 bitcoin in May, or an average rate of 4.5 BTC per day. Peak capacity hit 10.4 EH/s while average hashrate for the month stood at 8.5 EH/s. HIVE said its fleet efficiency remained steady at around 20 joules per terahash (J/TH), and its network share now exceeds 1% of global Bitcoin mining power. The new facility in Paraguay reflects a broader trend in the mining industry: the race to deploy next-generation ASIC miners rapidly and at scale in regions with abundant renewable power. Co-founder Frank Holmes emphasized the company's speed and flexibility, pointing to its Buzz HPC division, which supports AI cloud infrastructure alongside Bitcoin mining. CEO Aydin Kilic said the company's goal for the summer is 18 EH/s, and that fleet upgrades should allow for a daily BTC output of over 12 by the fourth quarter — potentially at a production cost below $50,000 per coin. HIVE operates facilities in Canada, Sweden and Paraguay, powered entirely by hydroelectricity. The company was the first publicly listed crypto miner on the TSX Venture Exchange in 2017. HIVE shares are higher by 13% in New York trade on Friday as the mining sector rallies alongside bitcoin's gain to above $105,000.
Associated Press
an hour ago
- Associated Press
Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
06/06/2025, Miami, Florida // PRODIGY: Feature Story // Anna Forsythe, founder of Oncoscope-AI (source: Oncoscope-AI) Oncoscope-AI, a revolutionary oncology intelligence platform, has officially launched following a successful beta phase and over a year of strategic development that involved extensive conversations with practicing oncologists. The platform, which delivers real-time, human-curated cancer insights enhanced by artificial intelligence, is now live and available free of charge to verified healthcare professionals worldwide. Founded by Anna Forsythe, a pharmacist, health economist, and seasoned pharmaceutical executive, Oncoscope addresses a critical gap in oncology care. It gives clinicians instant access to the most current treatment data, FDA approvals, and guideline-aligned information, consolidated into one user-friendly platform. 'Doctors do not need more data. They need the right information, at the right time, in a format they can use to make better decisions for their patients,' said Forsythe. 'Oncoscope provides that clarity. It is a living library of oncology, curated by experts and built to save lives.' Unlike generic AI tools or static databases, Oncoscope uses trained AI to scan thousands of oncology publications and filters them through a rigorous, evidence-based framework. Each entry is cross-referenced with clinical guidelines and regulatory approvals to ensure usability and relevance. All of the results are carefully scrutinized by a team of experienced researchers. Currently, the platform supports breast and lung cancer, with prostate, bladder, colon, and rectal modules rolling out in the coming months. The process is intuitive. Physicians answer three clinical questions—cancer stage, genetic markers, and prior treatments—and receive a personalized, actionable summary. Each recommended article includes survival data, progression insights, treatment efficacy, and toxicity, extracted across 32 key clinical parameters. 'The result is something physicians can actually use in the moment,' said Forsythe. 'It takes three clicks to go from a patient in the room to the most up-to-date evidence in the field.' Access to Oncoscope is free for verified healthcare professionals, including physicians, nurses, pharmacists, genetic counselors, and physician assistants. Non-verified users, such as those in finance or consulting, can purchase limited access at a monthly rate, restricted to a single cancer type. This structure reflects the company's commitment to empowering front-line clinicians with better tools—without barriers. Forsythe, who previously founded and sold a successful health economics company serving global pharmaceutical clients, brings a rare combination of clinical, technical, and business expertise to this venture. She sees Oncoscope not only as a tool, but as a mission. 'This platform was born from both professional insight and personal urgency,' she said. 'Too many patients are still receiving outdated treatments, simply because their doctors do not have time to stay current. I realized I had the knowledge, the team, and the experience to fix that.' With a lean team, strategic vision, and a rapidly growing user base, Oncoscope is poised to become a trusted global resource in cancer treatment. 'We are not just a tech company,' said Forsythe. 'We are part of the oncology ecosystem. And we are here to help doctors deliver the best care possible.' For more information, visit Media Contact: Name - Anna Forsythe Email - [email protected] Source published by Submit Press Release >> Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
